IP Library › Assignment 018303/0026
Patent Assignment
Reel/Frame 018303/0026

Change of Name

Recorded: 2006-09-26 Pages: 3
Assignor
PROTEIN DESIGN LABS, INC.
Executed: 2006-01-09
Assignee
PDL BIOPHARMA, INC.
34801 CAMPUS DRIVE, FREMONT, CALIFORNIA, 94555
Covered Properties (2)
Recombinant Antibody-Toxin Fusion Protein
Patent: 5,863,745 →
Application: 08/461,825 →
Recombinant Antibody-Toxin Fusion Protein
Patent: 5,696,237 →
Application: 08/463,163 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 15, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 023649/0752 →
Change of Name Dec 9, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025483/0591 →
Change of Name Dec 5, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 031722/0709 →